IDF Evening Webinar - Primary breast cancer: from surviving to thriving

Event Details

We are delighted to invite you to our Evening Webinar with Dr Nina Fuller-Shavel who will be presenting on Primary breast cancer - from surviving to thriving.

 This talk would be intended to be a back to the beginning look at where clinical genetics has come from and where next generation genetic testing has taken us. To shine a light towards more informed medicine of the near future. Minimising theory and focusing on a need to know basis for all doctors in practice.

With 1 in 7 women in the UK diagnosed with breast cancer (BC) within their lifetime and increasing survival rates, the number of breast cancer survivors is growing every year, yet these individuals often have very little ongoing care offered to them beyond recurrence surveillance. The end of primary breast cancer treatment often leads to a precipitous drop in support at a time when most survivors are still struggling and perhaps feel even more at sea outside the structure of hospital appointments and intensive treatment plans. Breast cancer survivorship care offers an excellent opportunity to change health trajectories for patients in the long term. Multimodal survivorship programmes, including digital health solutions, provide an opportunity to tackle residual post-treatment or endocrine therapy-related symptoms, to support good quality of life and physical and psychological recovery, and to improve overall survival. Beyond the risk of BC recurrence, BC survivors have a disproportionate risk of other long-term complications, e.g. metabolic syndrome, cardiovascular disease (CVD) and hypothyroidism, as compared to the general population. Proactive assessment and management of insulin resistance, fasting lipid profile, inflammatory markers and thyroid function is important to support post-treatment recovery and better quality of life and to improve overall survival through reducing mortality related to excessive CVD risk.

Learning objectives:

• Discuss common post-treatment sequelae of primary breast cancer treatment and available strategies to tackle residual symptoms and support good quality of life in BC survivorship.
• Review long-term metabolic, cardiovascular and endocrine disease risks for breast cancer.

PLEASE NOTE

Certificates of Attendance will be sent to those that have attended the full webinar. A Structured Reflective Template will be sent to you along with the link to join our webinar at least 24 hours ahead. Please ensure you are registered via our website in order that you receive a link to access the webinar.

We have prepared the IDF Zoom Webinar Software 10 Step Guide if you need help joining our webinars.